RLAY
Relay Therapeutics, Inc.
Stock
$18.96+0.47 (+2.54%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $62M
- YoY, 2025
- −33.7%
- 5-year CAGR
- +14.3%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $62M | −33.7% |
| 2024 | $94M | +9.4% |
| 2023 | $86M | +53.2% |
| 2022 | $56M | +15.9% |
| 2021 | $48M | +51.6% |
| 2020 | $32M | +617.2% |
| 2019 | $4.5M | — |